FDA Grants Fast Track Designation to Diffuse Large B-Cell Lymphoma Drug Candidate
https://pixabay.com/en/thumbs-up-okay-good-well-done-2056022/

FDA Grants Fast Track Designation to Diffuse Large B-Cell Lymphoma Drug Candidate

According to a press release from the New Jersey-based biotechnology company Cellectar Biosciences, the Food and Drug Administration (FDA) has granted "Fast Track" designation to the Company's experimental diffuse large…

Continue Reading FDA Grants Fast Track Designation to Diffuse Large B-Cell Lymphoma Drug Candidate